GATA 3 - Is it a prognostic marker in Breast Carcinoma?

Original Article – “GATA 3 - Is it a prognostic marker in Breast Carcinoma?” International Journal of Advance Research 9(01), 1008- 1012

Effect of Tamoxifen on Fasting Serum Lipid Profile In Breast Cancer Patients

“Effect of Tamoxifen on Fasting Serum Lipid Profile In Breast Cancer Patients” International Journal of Advance Research 9(01), 1013- 1018

“HER2/neu- A prognostic marker for Ovarian Carcinoma” Middle East Journal of Cancer 2009-1465 (under publication)

“HER2/neu- A prognostic marker for Ovarian Carcinoma” Middle East Journal of Cancer 2009-1465 

Lipid Profile and Its Significance in Breast Cancer

“Lipid Profile and Its Significance in Breast Cancer” International Journal of Advance Research 8(10), 1241-1248

Correlation of anthracycline induced early onset chronic cardio toxicity with pro BNP and echocardiography

“Correlation of anthracycline induced early onset chronic cardio toxicity with pro BNP and echocardiography” International Journal of Advance Research 8(01), 1078-1084

Role of Vitamin E In Prevention of Chemotherapy Induced Peripheral Neuropathy

"Role of Vitamin E In Prevention of Chemotherapy Induced Peripheral Neuropathy” International Journal of Advance Research 8(06), 1260-1265

Prevalence of p53 Mutation in serous Carcinoma Ovary and its Predictive Value for Response to Platinum-Based Chemotherapy

“Prevalence of p53 Mutation in serous Carcinoma Ovary and its Predictive Value for Response to Platinum-Based Chemotherapy” International Journal of Innovative Science & Research Technology 12(06), 62- 67

Vitamin D Deficiency and Its Relationship with Child-Pugh class in Patients with Chronic Liver Disease

“Vitamin D Deficiency and Its Relationship with Child-Pugh class in Patients with Chronic Liver Disease” Journal of Clinical and Translational Hepatology DOI: 10.14218/JCTH.2017.00055

Dr Anum Khan RMI

Dr. Anum Khan

Dr. Anum Khan is an experienced Consultant Medical Oncologist affiliated with RMI. She holds M.B.B.S and FCPS in Medical Oncology qualifications. Her professional journey includes roles at institutions such as Combined Military Hospital Peshawar, Afridi Medical Complex and Teaching Hospital Peshawar, and training at Fauji Foundation Hospital Rawalpindi.

Dr. Khan is also a passionate researcher, having contributed to the field with the publication of eight research papers in high-ranking journals.

Moreover, Dr. Khan possesses a special interest in female cancers and understands the unique challenges and concerns that come with them. She provides tailored care that addresses the specific needs of female patients, regardless of whether they have breast cancer, gynecologic cancer, or any other female-related condition.

Dr. Khan is a dedicated oncologist who is committed to providing best possible care to her patients. Her expertise and dedication make her an asset to the field of oncology and a trusted partner in your journey to better health.

  • Timings :
    09:00 am ~ 03:00 pm
  • Department: Oncology
  • Designation: Consultant Medical Oncology
Request Appointment

Expertise

  • Breast Cancer

  • Gynecologic oncology

  • Blood Cancer

  • Lung Cancer

  • Sarcomas

  • Gastrointestinal Cancers

  • Urogenital Cancers

  • Skin Cancer

  • Brain Tumor

  • Lymphoma

Qualification

  • MBBS
  • FCPS
img

Publication

Publications
Previous Next

Presentations/Workshops

Poster Presentations at

  • 19th Shaukat Khanum cancer symposium at Lahore in Nov 2020
  • PSCO 24th Annual Congress 2020.
  • Case report presentation at Shaukat Khanum cancer symposium at Lahore in Nov 2020

Awards/Honors

 

Professional membership

Pakistan Medical and Dental Council [71674-P]

European Society for Medical Oncology